Multimedia

Chemotherapy-Free Triplet 'Sets a New Benchmark' in Follicular Lymphoma
'This Would Be a Hugely Important Finding': What We Heard This Week
Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest
Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation
TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALL
The Internet's Risky Pseudo-Cures
Want Good Info on Epilepsy Treatment? Don't Ask Dr. TikTok
Fixed-Duration or Continuous Therapy in CLL: Trial Says Take Your Pick